Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

AI Stock Picker
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Resources

Blog
Earnings
Tutorial
Partner Program

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. VYNE
    4. >
  4. Valuation

Valuation

-
stocks logo
VYNE
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is VYNE Overvalued？

VYNE is now in the zone, suggesting that VYNE current forward PE ratio of -2.26 is considered compare with the five-year average of -2.19.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

VYNE Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
VYNE.O
Vyne Therapeutics Inc
loss
Average P/E: 110.50
84.57%
40.42M
stocks logo
KALA.O
KALA BIO Inc
loss
Average P/E: 110.50
43.33%
40.45M
stocks logo
SCYX.O
SCYNEXIS Inc
110.50
Average P/E: 110.50
-57.43%
40.61M
stocks logo
GBIO.O
Generation Bio Co
loss
Average P/E: 110.50
46.50%
40.76M
stocks logo
ATRA.O
Atara Biotherapeutics Inc
loss
Average P/E: 110.50
-347.35%
40.95M
stocks logo
BRNS.O
Barinthus Biotherapeutics PLC
loss
Average P/E: 110.50
43.63%
40.23M

VYNE Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

VYNE FAQs

Is VYNE currently overvalued based on its P/E ratio?

According to the provided data, VYNE's 5-year historical average forward P/E ratio is -2.19. VYNE forward P/E ratio is -2.26, which is categorized as Fair.

How has VYNE's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable decrease from 1.15 to 0.57, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for VYNE?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has VYNE's Price to Sales (PS) ratio evolved?

The PS ratio increased from 121.33 to 151.61, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for VYNE's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

VYNE PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-2.19
Current PE
-2.26
Overvalued PE
-0.73
Undervalued PE
-3.66

VYNE EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-0.13
Current EV
0.63
Overvalued EV
1.20
Undervalued EV
-1.47

VYNE P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
50.74
Current PS
84.49
Overvalued PS
98.00
Undervalued PS
3.48

VYNE Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
VYNE.O
Vyne Therapeutics Inc
loss
Average P/E: 110.50
84.57%
40.42M
stocks logo
KALA.O
KALA BIO Inc
loss
Average P/E: 110.50
43.33%
40.45M
stocks logo
SCYX.O
SCYNEXIS Inc
110.50
Average P/E: 110.50
-57.43%
40.61M
stocks logo
GBIO.O
Generation Bio Co
loss
Average P/E: 110.50
46.50%
40.76M
stocks logo
ATRA.O
Atara Biotherapeutics Inc
loss
Average P/E: 110.50
-347.35%
40.95M
stocks logo
BRNS.O
Barinthus Biotherapeutics PLC
loss
Average P/E: 110.50
43.63%
40.23M

VYNE Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is VYNE undervalued？Is VYNE overvalued compared to its competitors？

VYNE FAQs

Is VYNE currently overvalued based on its P/E ratio?

According to the provided data, VYNE's 5-year historical average forward P/E ratio is -2.19. VYNE forward P/E ratio is -2.26, which is categorized as Fair.

How has VYNE's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable decrease from 1.15 to 0.57, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for VYNE?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has VYNE's Price to Sales (PS) ratio evolved?

The PS ratio increased from 121.33 to 151.61, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for VYNE's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is VYNE undervalued？Is VYNE overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
AI Stock PickerFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisStock Chart PatternsEarnings TradingAI Screener
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free